Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells

Kidney International

Volumn 68, Issue 6, 2005, Pages 2756-2765

  Ballinger, Mandy L ^b   Thomas, Merlin C ^b   Nigro, Julie ^b   Ivey, Melanie E ^b   Dilley, Rodney J ^b   Little, Peter J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b NONE

Author keywords

Advanced glycation end products; Atherosclerosis; De novo protein synthesis; Fluorescence; Glucose consumption; N (carboxymethyl)lysine; Proteoglycans; RAGE; Vascular smooth muscle

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; PROTEOGLYCAN; SULFATE; SULFUR 35;

ARTICLE; ATHEROSCLEROSIS; CARBOXYLATION; CELL ACTIVATION; CELL LABELING; CELL LINE; CELLULAR DISTRIBUTION; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 32844465045     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00746.x     Document Type: Article

References (41)

1. VLASSARA H, PALACE MR: Diabetes and advanced glycation end-products. J Intern Med 251:87-101, 2002
2. COOPER ME, BONNET F, OLDFIELD M, JANDELEIT-DAHM K: Mechanisms of diabetic vasculopathy: An overview. Am J Hypertens 14:475-486, 2001
3. PANAGIOTOPOULOS S, O'BRIEN RC, BUCALA R, et al: Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit. Atherosclerosis 136:125-131, 1998
4. WOLFFENBUTTEL BH, BOULANGER CM, CRIJNS FR, et al: Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630-4634, 1998
5. SCHMIDT AM, YAN SD, WAUTIER JL, STERN D: Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-197, 1999
6. BURKE AP, KOLODGIE FD, ZIESKE A, et al: Morphologic findings of coronary atherosclerotic plaques in diabetics. A postmortem study. Arterioscler Thromb Vasc Biol 24:1266-1271, 2004
7. STITT AW, HE C, FRIEDMAN S, et al: Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3:617-627, 1997
8. PALINSKI W, KOSCHINSKY T, BUTLER SW, et al: Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vasc Biol 15:571-582, 1995
9. KUME S, TAKEYA M, MORI T, et al: Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667, 1995
10. SUN M, YOKOYAMA M, ISHIWATA T, ASANO G: Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat. Int J Exp Pathol 79:207-222, 1998
11. RENARD CB, ASKARI B, SUZUKI LA, et al: Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells. Diabetologia 46:1676-1687, 2003
12. ROSS R: Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126, 1999
13. NEYLON CB, LITTLE PJ, CRAGOE EJ, JR., BOBIK A: Intracellular pH in human arterial smooth muscle. Regulation by Na+/H+ exchange and a novel 5-(N-ethyl-N-isopropyl)amiloride-sensitive Na(+)- and HCO3(-)-dependent mechanism. Circ Res 67:814-825, 1990
14. POUYSSEGUR J, FRANCHI A, SILVESTRE P: Relationship between increased aerobic glycolysis and DNA synthesis initiation studied using glycolytic mutant fibroblasts. Nature 287:445-447, 1980
15. BOBIK A, GROOMS A, LITTLE PJ, et al: Ethyisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth. Am J Physiol 260:C581-C588, 1991
16. WILLIAMS KJ, TABAS I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561, 1995
17. MAKITA Z, VLASSARA H, CERAMI A, BUCALA R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
18. KISLINGER T, FU C, HUBER B, et al: N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740-31749, 1999
19. HABEEB AF: Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328-336, 1966
20. SUDHIR K, HASHIMURA K, BOBIK A, et al: Mechanical strain stimulates a mitogenic response in coronary vascular smooth muscle cells via release of basic fibroblast growth factor. Am J Hypertens 14:1128-1134, 2001
21. SUZUKI LA, POOT M, GERRITY RG, BORNFELDT KE: Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth-promoting effects of high glucose levels. Diabetes 50:851-860, 2001
22. LITTLE PJ, TANNOCK L, OLIN KL, et al: Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol 22:55-60, 2002
23. SCHONHERR E, JARVELAINEN HT, SANDELL LJ, WIGHT TN: Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266:17640-17647, 1991
24. SCHONHERR E, JARVELAINEN HT, KINSELLA MG, et al: Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb 13:1026-1036, 1993
25. NIGRO J, DILLEY RJ, LITTLE PJ: Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells. Atherosclerosis 162:119-129, 2002
26. FORBES JM, YEE LT, THALLAS V, et al: Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53:1813-1823, 2004
27. BALLINGER M, NIGRO J, FRONTANILLA K, et al: Regulation of glycosaminoglycan structure and atherogenesis. Cell Mol Life Sci 61:1296-1306, 2004
28. DE DIOS ST, BRUEMMER D, DILLEY RJ, et al: Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. Circulation 107:2548-2550, 2003
29. SKALEN K, GUSTAFSSON M, RYDBERG EK, et al: Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750-754, 2002
30. CAMEJO G: The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis. Adv Lipid Res 19:1-53, 1982
31. PLUTZKY J: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88:10K-15K, 2001
32. FALK E, FERNANDEZ-ORTIZ A: Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 75:3B-11B, 1995
33. BASTA G, LAZZERINI G, MASSARO M, et al: Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses. Circulation 105:816-822, 2002
34. CANDIDO R, JANDELEIT-DAHM KA, CAO Z, et al: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106:246-253, 2002
35. BIERHAUS A, SCHIEKOFER S, SCHWANINGER M, et al: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792-2808, 2001
36. SOULIS T, THALLAS V, YOUSSEF S, et al: Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40:619-628, 1997
37. CHANG MY, POTTER-PERIGO S, TSOI C, et al: Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem 275:4766-4773, 2000
38. CAMPBELL JH, CAMPBELL GR: Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci 85:501-513, 1993
39. WILSON E, MAI Q, SUDHIR K, et al: Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 123:741-747, 1993
40. SAKATA N, MENG J, TAKEBAYASHI S: Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb 7:169-176, 2000
41. SARDET C, COUNILLON L, FRANCHI A, POUYSSEGUR J: Growth factors induce phosphorylation of the Na+/H+ antiporter, glycoprotein of 110 kD. Science 247:723-726, 1990